PGPreethi Sara George

Preethi Sara George

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Preethi Sara George has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Validation of the Malayalam Version of Body Image Scale and Assessment of the Impact of Breast Cancer Surgery on Body Image

    by Chaitanya Morpuri Kumar Reddy, Rexeena Bhargavan, Preethi S. George, Kurian Cherian, Paul Augustine

  • Intermittent state-wise survival risk estimation in breast cancer patients using a multi-state frailty model

    by Divya Dennis, Anand Hari, Preethi Sara George, Aleyamma Mathew, Rajeev Kavalakara Raghavan, Jagathnath Krishna Kumarapillai Mohanan Nair

  • Open Access

    Efficacy of ultrasound versus video-bronchoscopy in confirming correct placement of i-gel®: A prospective observational study

    by S Amina, O Rajasree, Mallika Balakrishnan, Frenny A Philip, Preethi S George

    Background and Aims: Supraglottic airway devices (SADs), such as the i-gel ® , are widely used during general anaesthesia but are susceptible to intraoperative displacement. Although clinical methods are commonly employed for confirming placement, they may be unreliable in identifying malposition. Video bronchoscopy (VB) is the gold standard for confirmation of proper SAD placement, but its use is limited by both cost and availability. Ultrasonography (US) is a non-invasive and cost-effective yet underutilised alternative. This study aimed to evaluate the efficacy of US in detecting I-gel ® placement compared with VB. Methods: In this prospective observational study, 155 female patients undergoing general anaesthesia were assessed. Pre- and post-I-gel ® insertion glottic images were obtained using US, followed by VB to determine I-gel ® positioning. Post I-gel ® insertion US images were graded based on asymmetrical arytenoid cartilage elevation (0–3 scale) relative to the glottic midline and contralateral arytenoid. These grades were then correlated with VB-assessed I-gel ® position and rotation status. Results: US detected arytenoid displacement in 27% of cases. VB revealed I-gel ® rotation in 63% and malposition in 21.9%. The sensitivity of US in detecting correctly positioned I-gel ® was 77.69% [95% confidence interval (CI): 69.22, 84.75], with a positive predictive value (PPV) of 83.19% (95% CI: 74.99, 89.56). For identifying non-rotated I-gel ® , US showed a sensitivity of 91.07% (95% CI: 80.38, 97.04) but a lower PPV of 45.13% (95% CI: 35.75, 54.77). Conclusion: US is effective in detecting I-gel ® displacement, but its ability to distinguish malposition from rotation is limited. VB remains the definitive modality for confirming accurate SAD positioning.


  • Expression of Programmed Death Ligand 1 (PD-L1) in Classical Hodgkin Lymphoma– Study from a Tertiary Care Cancer Centre in South India

    by P. K. Pravanya, Priya Mary Jacob, Rekha A. Nair, Deepa Susan Joy Philip, N. P. Prakash, Preethi Sara George, A. V. Jayasudha

    Classical Hodgkin lymphoma (CHL) has an overall favourable prognosis. However, relapse/refractory CHL cases are associated with an unfavourable outcome. Targeted immunotherapy based on PD-1 and PD-L1 pathway inhibitors have shown improvement in the treatment of relapsed/refractory CHL cases. The objective of this study was to assess Programmed death ligand (PD-L1) expression before and after antineoplastic treatment in primary refractory (P/R) Classical Hodgkin lymphoma and relapsed/ refractory (R/R) Classical Hodgkin lymphoma cases. Slides and blocks of 30 paired biopsies of Classical Hodgkin Lymphoma cases during the five year study period which have been refractory or have relapsed post antineoplastic treatment were retrieved and reviewed. PD-L1 expression in Hodgkin Reed Sternberg (HRS) cells and micro environment (ME) at primary diagnosis and at relapse/refractory disease were analysed by staining with PD-L1 (SP263) antibody. Tumour cells and peritumoral microenvironment were evaluated separately. More than 5% expression with 2+/3+ intensity in HRS cells and/or in microenvironment were accepted as positive. In our patient population we found that the PD-L1 expression in relapse/refractory lymphoma biopsy in comparison to primary diagnosis biopsy remains largely unchanged in HRS cells and in the microenvironment. This stable expression of PD-L1 expression in paired biopsies suggests that PD-L1 inhibitors can be used as second line therapy in all relapsed Classical Hodgkin lymphoma patients without PD-L1 testing.

  • Open Access

    A Prospective Study of the Efficacy of Endofascial Axillary Dissection to Reduce Axillary Seroma Formation

    by Paul Augustine, Srinidhi M., Rexeena Bhargavan, Shafeek Shamshudeen, Kurien Cherian, Preethi Sara George

    Introduction Seroma formation is a common complication following axillary dissection. The pathogenesis of seroma is poorly understood. Various chemical and mechanical methods have been tried to reduce seroma with varying results. In this study, we look at a novel method of axillary dissection to reduce seroma and its attendant morbidity. The objective of the study is to compare endofascial axillary lymphadenectomy with routine axillary lymphadenectomy regarding axillary drain output following breast conservation surgery. Methods We did a prospective interventional study of endofascial axillary dissection in patients undergoing breast conservation surgery. Comparison was done with historical controls who underwent breast conservation surgery with routine axillary lymphadenectomy before the study period. All patients were operated by the same surgeon. Results Breast conservation surgery with endofascial axillary dissection was performed in 36 patients and compared with 36 patients who underwent routine axillary dissection before the study period. The mean total axillary drain output in the endofascial and routine groups were 796.8 and 1,259.3 mL, respectively (p = 0.001). The average day of drain removal in the endofascial and routine groups were 10.8 and 14.9 days, respectively (p = 0.001). The nodal yield of the endofascial and routine groups were 15.3 and 16.4 nodes, respectively (p = 0.449). The duration of surgery of the endofascial and routine groups were 89.3 and 85.1 minutes, respectively (p = 0.366). Conclusion Endofascial axillary dissection significantly reduced the mean total axillary drain output and resulted in early drain removal compared with routine axillary dissection. There were no significant differences in the nodal yield, operative time, seroma aspirations, and wound complications between the endofascial and routine axillary dissection groups.


  • Open Access

    Reconstructive Head and Neck Microsurgery in a High-Volume Cancer Center—Long-Term Impact of an Early Experience

    by Bipin T. Varghese, Shaji Thomas, Sourabh Arora, Preethi George, Iype Em, Balagopal Pg, Aniraj R., Vijayakumar P., Deepthi Simon, Amrita Rao

    The aim of this study was to evaluate a 16-year-long outcome of an evolving practical approach to reconstructive microsurgery in a high volume, resource-constrained, head and neck cancer care setting. Seventy-three consecutive cases of free flap reconstruction done by the Head and Neck Surgical Oncology team of Regional Cancer Centre, Thiruvananthapuram, from October 2004 to May 2020 were prospectively studied for flap viability, cosmesis, morbidity, and oncologic safety. The cases were selected based on their “emphatic” superiority to the conventional alternative as determined by two or more surgeons of the head and neck team or the recommendations of the head and neck tumor board. With the long-term results, this article discusses and validates our strategy for controlled patient recruitment for reconstructive microsurgery to ensure the best resource utilization in a tertiary cancer care center. Adequate training and optimal application are the key factors determining success in microvascular reconstructive surgery in resource-constrained, high-volume cancer care facilities.

  • Open Access

    Efficacy of a herbal mouthwash for management of periodontitis and radiation-induced mucositis – A consolidated report of two randomized controlled clinical trials

    by R. Ambili, K. Ramadas, Lekha M. Nair, Divya Raj, Farida Nazeer, Preethi Sara George, R. Rejnish Kumar, M. Radhakrishna Pillai


  • Open Access

    Spatiotemporal pattern of thyroid cancer incidence in South Kerala: A population-based study

    by PreethiSara George, Aleyamma Mathew, S Sruthi, SreekumarAnanthakrishna Kurup, Jayasree Kattoor, Tr Vinod

    Asons for this increase have not been established. Objectives: Here, we investigated the spatiotemporal pattern of TC incidence in Thiruvananthapuram. Materials and Methods: TC incidence data (n = 1937) of Population Based Cancer Registry Thiruvananthapuram, Kerala, India, between 2012 and 2016, were analyzed for identifying geographical patterns by spatial methods, temporal methods for studying spatial variation in TC incidence, distribution of age, gender, and histology in lowland (coastal), midland, and highland. Results: Spatial clustering of TC incidence was identified consistently near the coastal region based on all geospatial analyses. 56.9%, 23.9%, and 19.2% of TC cases were observed in the coastal, midland, and highland areas, respectively. A significant clustered pattern of TC incidence was revealed by Moran’s index I (0.49), high-high clusters by local Moran’s, hotspot by Getis-Ord-Gi* (P < 0.05), point pattern analysis by nearest neighbor ratio and kernel density estimation. The relative risk of the significant cluster was obtained as 1.60 (95% confidence interval: 1.03–1.84) by SaTScan analysis. Conclusion: This study identified spatial variations in the pattern of TC cases with significant clusters near the coastal region of Thiruvananthapuram. This would help to pinpoint the high-risk geographical areas of TC and for more effective cancer control programs....


  • Open Access

    Treatment Outcomes of Adenoid Cystic Carcinomas of the Head and Neck Region—A Single-Institution Experience

    by Malu Rafi, Rejnish Kumar, Kainickal Cessal Thomas, Nebu Abraham George, Preethi Sara George, Kunnambath Ramadas

    Objectives This study was undertaken to evaluate the characteristics and treatment outcomes of patients with adenoid cystic carcinomas of the head and neck region treated at a tertiary cancer center in south India. Materials and Methods This was a retrospective study done on patients treated at the institute between 2004 and 2011. Clinicopathological details and treatment outcomes were captured from the treatment records to estimate the treatment outcomes and factors affecting them. Results There were a total of 140 patients with mean age of presentation of 46 years and a median follow-up of 65 months. The most common single site of presentation was the oral cavity. One-hundred eighteen patients (84.3%) underwent primary surgical resection in which 38% had negative surgical margins. Ninety-nine patients were given adjuvant radiotherapy and 18 patients received radical radiotherapy, mostly for surgically inaccessible and inoperable tumors. Median time to recurrence and distant metastasis was 37 and 34 months, respectively. The overall survival and disease-free survival estimate using the Kaplan–Meier method were 92.3 and 71.9%, respectively, at 5 years. Surgical removal of the primary tumor and the nodal stage had the most significant impact on the overall survival outcomes of these patients. Conclusion Surgery remains the most impactful treatment modality in the management of these rare epithelial tumors. The use of adjuvant radiotherapy may help to tackle the issues of perineural spread and inadequate surgical margins in technically difficult sites. Radical radiotherapy also has impressive response rates.


  • Open Access

    Educational Status, Cancer Stage, and Survival in South India: A Population-Based Study

    by Aleyamma Mathew, Preethi Sara George, Ramadas Kunnambath, Beela Sarah Mathew, Aswin Kumar, Roshni Syampramod, Christopher M. Booth

    PURPOSE: Lower socioeconomic status is associated with more advanced cancer at the time of cancer diagnosis. It is unknown whether this leads to inferior survival in low- and middle-income countries. Here, we explore the association between educational level and survival in South India. METHODS: The Trivandrum Cancer Registry (3.3 million population) was used to identify all cases of breast and cervical cancer (women) and oral cavity (OC) and lung cancer (men) diagnosed during 2012-2014. Educational level was classified as illiterate/primary school, middle school, and secondary school and above. Survival was measured from date of diagnosis using the Kaplan-Meier method. Cox proportional hazards regression modeling was used to describe the associations among education, stage of cancer at diagnosis, and survival. RESULTS: The study population included 3,640 patients with breast (n = 1,727), cervical (n = 425), OC (n = 702), and lung (n = 786) cancer. Educational level was 27%, 23%, and 32% for illiterate/primary, middle, and secondary school and above, respectively. The 5-year survival rate for breast cancer was 59%, 68%, and 73% ( P = .001); for cervical cancer, 51%, 52%, and 60% ( P = .146); and for OC cancer, 42%, 35%, and 48% ( P = .012) for illiterate/primary, middle school, and secondary school and above, respectively. The survival gradient across social groups was substantially attenuated when stage was added to the multivariable model. There was no observed difference in survival across educational groups for lung cancer (2%, 4%, and 3%; P = .224). CONCLUSION: Data from this population-based study in South India demonstrate that patients from a lower educational background have inferior survival and that this is at least partially explained by having more advanced disease at the time of diagnosis. Public health efforts are needed to facilitate timely diagnosis and reduce disparities in cancer outcomes.